Use of budesonide in the treatment of microscopic colitis.

Abstract

Collagenous colitis and lymphocytic colitis, the two types of microscopic colitis, cause watery diarrhea. Budesonide, a glucocorticoid medication with limited systemic availability, is commonly used to treat these illnesses. Budesonide has proven efficacy in the induction of clinical remission in both collagenous colitis and lymphocytic colitis. Budesonide is effective as a maintenance drug for patients with collagenous colitis, but has not been studied for this indication in patients with lymphocytic colitis. This drug improves quality of life in patients while causing few mild adverse events. Budesonide is an effective treatment of microscopic colitis that is safe and well tolerated.

• Authors: Vikram Tangri, Nilesh Chande
• Journal: Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association (Saudi J Gastroenterol) 2010 Jul-Sep Vol. 16 Issue 3 Pg. 236-8 ISSN: 1998-4049 [Electronic] India
• PMID: 20616427 (Publication Type: Journal Article, Review)

Chemical References

• Glucocorticoids
• Budesonide

Topics

• Budesonide (adverse effects, therapeutic use)
• Colitis, Microscopic (drug therapy)
• Glucocorticoids (adverse effects, therapeutic use)
• Humans
• Quality of Life
• Randomized Controlled Trials as Topic
• Remission Induction